immatics biotechnologies GmbH
Patents, Design & Utilities

Last updated:

List of all immatics biotechnologies GmbH patents 820 in total

Status Patent
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Mar 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Mar 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 24 Feb 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 17 Feb 2022
Grant
Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods External link
Filling date: 8 Sep 2025 Issue date: 15 Feb 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 15 Feb 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 15 Feb 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 10 Feb 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 3 Feb 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 3 Feb 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Feb 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Feb 2022
Grant
Utility: T cell receptors and immune therapy using the same against PRAME positive cancers External link
Filling date: 8 Sep 2025 Issue date: 1 Feb 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 27 Jan 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 25 Jan 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 20 Jan 2022
Application
Utility: MAGEB2 BINDING CONSTRUCTS External link
Filling date: 8 Sep 2025 Issue date: 20 Jan 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 8 Sep 2025 Issue date: 18 Jan 2022
Application
Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER External link
Filling date: 8 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: IMMUNOTHERAPY WITH B*08 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: IMMUNOTHERAPY WITH B*08 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 6 Jan 2022
Application
Utility: IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 6 Jan 2022
Application
Utility: IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 6 Jan 2022
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 6 Jan 2022
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 8 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: Peptides for use in immunotherapy against cancers External link
Filling date: 8 Sep 2025 Issue date: 4 Jan 2022
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS External link
Filling date: 8 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 30 Dec 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 30 Dec 2021
Grant
Utility: Immunotherapy against several tumors including neuronal and brain tumors External link
Filling date: 8 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Peptides for use in immunotherapy against cancers External link
Filling date: 8 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods External link
Filling date: 8 Sep 2025 Issue date: 28 Dec 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS External link
Filling date: 8 Sep 2025 Issue date: 23 Dec 2021

Showing 100 to 150 of 820 patents.